Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods.
R J Levine, J R Esterlitz, E G Raymond...
https://pubmed.ncbi.nlm.nih.gov/8932976Completed
Led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Updated on 2017-03-13
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
To evaluate the efficacy of 2 grams per day of oral calcium supplementation in reducing the combined incidence of hypertensive disorders of pregnancy: pre-eclampsia, eclampsia, and the HELLP Syndrome (hypertension, thrombocytopenia, hemolysis, and abnormal liver function). The National Institute of Child Health and Human Development (NICHD) initiated the trial in 1991, with joint funding provided by the National Heart, Lung, and Blood Institute in fiscal years 1992, 1993, and 1995.
CONDITIONS
Calcium for Pre-Eclampsia Prevention (CPEP)
You may qualify if you...
Nulliparous, normotensive, pregnant women.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Site Locations not provided
Location information for this trial is currently unavailable.
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
N/A
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
R J Levine, J R Esterlitz, E G Raymond...
https://pubmed.ncbi.nlm.nih.gov/8932976B M Sibai, M Ewell, R J Levine...
https://pubmed.ncbi.nlm.nih.gov/9396883J L Mills, R DerSimonian, E Raymond...
https://pubmed.ncbi.nlm.nih.gov/10432033G M Joffe, J R Esterlitz, R J Levine...
https://pubmed.ncbi.nlm.nih.gov/9790393R J Levine, J C Hauth, L B Curet...
https://pubmed.ncbi.nlm.nih.gov/9211675